Mining
Aton drills further high grade gold-polymetallic sulphide mineralisation at Rodruin, returning 7.04 g/t gold, 47.2 g/t silver, 0.63% copper and 7.18% zinc over 36.9 metres
VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) — Aton Resources Inc. (AAN: TSX-V) (“Aton” or the “Company”) is pleased to update investors on the latest results from the Phase 2 diamond drilling programme at more...
Mining
American Lithium Adds Further Concessions Close to Its Existing Projects in Southern Peru
VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the Company”) (TSX-V: LI, OTCQB: LIACF, Frankfurt: 5LA1) is pleased to confirm that it has signed an agreement to acquire more...
Health
BIOLASE CREATES FIRST-OF-ITS-KIND CLINICAL INTEGRATION TEAM
BIOLASE CREATES FIRST-OF-ITS-KIND CLINICAL INTEGRATION TEAM PR Newswire Multi-dimensional team of leading specialists, general dentists and hygienists will support the rapid adoption of BIOLASE dental lasers in practices across North America LAKE FOREST, Calif. , more...
Biotech
Affimed Reports First Quarter 2022 Financial Results and Highlights Recent Operational Progress
AFM13 monotherapy: Completed enrollment in the REDIRECT study for patients with relapsed or refractory PTCL; on track to report topline data in the fourth quarter of 2022 AFM13 combination with NK cells: Reported data at more...
Tech
Alithya to acquire Datum, adding recurring SaaS revenues and growing global capabilities
Alithya to acquire Datum, adding recurring SaaS revenues and growing global capabilities PR Newswire High-value insurance-focused intellectual property portfolio MONTREAL , June 1, 2022 /PRNewswire/ – Alithya Group inc. (TSX: ALYA) (NASDAQ: ALYA) (“Alithya”) is more...
Cannabis
InvestmentPitch Media Video Discusses FSD Pharma’s Submission of an Investigational New Drug or “IND” Application with the U.S. Food and Drug Administration and Health Canada for Treatment of a Yet-To-Be-Disclosed Inflammatory Disorder
VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) — FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, has submitted an Investigational New more...